Epidemiological characteristics, reinfection possibilities and vaccine development of SARS CoV2: A global review

According to the World Health Organization (WHO), there are 37,704,153 cases and 10,79,029 deaths due to COVID-19 till the 13th October 2020 in the world. Day by day, rise in the number of COVID-19 deaths has created great pressure on health facilities, governmental bodies, and health workers. There...

Full description

Saved in:
Bibliographic Details
Published in:Journal of family medicine and primary care 2021-03, Vol.10 (3), p.1095-1101
Main Authors: Yadav, Ramakant, Bajpai, Prashant K, Srivastava, Dhiraj K, Kumar, Raj
Format: Article
Language:English
Subjects:
Review
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c290t-68a6cd4776edfe77417104aaa80fcea5190b99a063f3da1517b8d7872c0d03cb3
cites cdi_FETCH-LOGICAL-c290t-68a6cd4776edfe77417104aaa80fcea5190b99a063f3da1517b8d7872c0d03cb3
container_end_page 1101
container_issue 3
container_start_page 1095
container_title Journal of family medicine and primary care
container_volume 10
creator Yadav, Ramakant
Bajpai, Prashant K
Srivastava, Dhiraj K
Kumar, Raj
description According to the World Health Organization (WHO), there are 37,704,153 cases and 10,79,029 deaths due to COVID-19 till the 13th October 2020 in the world. Day by day, rise in the number of COVID-19 deaths has created great pressure on health facilities, governmental bodies, and health workers. There is a need for knowledge regarding lifecycle, transmission, and different strains of SARSCoV2, so that countries can stop the disease as early as possible. The present study was conducted to review various epidemiological aspects along with measures used in the containment and prevention of this new pandemic. The scientific literature database was searched using the terms: coronavirus, 2019-nCoV, SARSCoV2, and COVID-19. Articles with appropriate topics fulfilling the objective of the present work were included. The epidemiological characteristics regarding life-cycle, intermediate hosts, viability on various surfaces, strains, case fatality rate, and their implication to reduce the transmission of SARSCoV2 have been identified. According to Centers for Disease Control and Prevention, Atlanta (updated till October 05, 2020) people with recurrent or persistent positive COVID-19 tests in South Korea and USA did not show to have live virus in their bodies. As per WHO web-page information till 15 October 2020, there were 42 candidate vaccines in clinical evaluation and 156 vaccines are in preclinical evaluation phase. As the virus can easily be transmitted to the people either via droplets, fomites, and may be via the fecal-oral route, knowledge regarding the above-mentioned areas is needed for time to be prepared for the next waves of the COVID-19 pandemic.
doi_str_mv 10.4103/jfmpc.jfmpc_2151_20
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8140278</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2533313451</sourcerecordid><originalsourceid>FETCH-LOGICAL-c290t-68a6cd4776edfe77417104aaa80fcea5190b99a063f3da1517b8d7872c0d03cb3</originalsourceid><addsrcrecordid>eNpVUU1v1DAQtRCIVqW_AAn5yIEUO3bihAPSalU-pEpIFLhaE3uyncqJg51dxL_HZUtF5zAzmo83o_cYeynFhZZCvb0dp8Vd_PW2lo20tXjCTuvadJWRqnl6l-u-0l2rTth5zreiWC9LrXvOTpQWWkrVnrLlciGPE8UQd-QgcHcDCdyKifJKLr_hCWke0a0UZ77EnGmgQCth5jB7fgDnaEbu8YAhLhPOK48jv958vebb-KN-xzd8F-JQkBMeCH-9YM9GCBnP7-MZ-_7h8tv2U3X15ePn7eaqcnUv1qrtoHVeG9OiH9EYLY0UGgA6MTqERvZi6HsQrRqVh0KAGTpvOlM74YVygzpj74-4y36Y0LvyWIJgl0QTpN82AtnHnZlu7C4ebCe1KDQWgNf3ACn-3GNe7UTZYQgwY9xnWzdKKal0I8uoOo66VAhKOD6ckcLeyWWPQj2Sq2y9-v_Dh51_4qg_qpmWtQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2533313451</pqid></control><display><type>article</type><title>Epidemiological characteristics, reinfection possibilities and vaccine development of SARS CoV2: A global review</title><source>PubMed Central</source><creator>Yadav, Ramakant ; Bajpai, Prashant K ; Srivastava, Dhiraj K ; Kumar, Raj</creator><creatorcontrib>Yadav, Ramakant ; Bajpai, Prashant K ; Srivastava, Dhiraj K ; Kumar, Raj</creatorcontrib><description>According to the World Health Organization (WHO), there are 37,704,153 cases and 10,79,029 deaths due to COVID-19 till the 13th October 2020 in the world. Day by day, rise in the number of COVID-19 deaths has created great pressure on health facilities, governmental bodies, and health workers. There is a need for knowledge regarding lifecycle, transmission, and different strains of SARSCoV2, so that countries can stop the disease as early as possible. The present study was conducted to review various epidemiological aspects along with measures used in the containment and prevention of this new pandemic. The scientific literature database was searched using the terms: coronavirus, 2019-nCoV, SARSCoV2, and COVID-19. Articles with appropriate topics fulfilling the objective of the present work were included. The epidemiological characteristics regarding life-cycle, intermediate hosts, viability on various surfaces, strains, case fatality rate, and their implication to reduce the transmission of SARSCoV2 have been identified. According to Centers for Disease Control and Prevention, Atlanta (updated till October 05, 2020) people with recurrent or persistent positive COVID-19 tests in South Korea and USA did not show to have live virus in their bodies. As per WHO web-page information till 15 October 2020, there were 42 candidate vaccines in clinical evaluation and 156 vaccines are in preclinical evaluation phase. As the virus can easily be transmitted to the people either via droplets, fomites, and may be via the fecal-oral route, knowledge regarding the above-mentioned areas is needed for time to be prepared for the next waves of the COVID-19 pandemic.</description><identifier>ISSN: 2249-4863</identifier><identifier>EISSN: 2278-7135</identifier><identifier>DOI: 10.4103/jfmpc.jfmpc_2151_20</identifier><identifier>PMID: 34041136</identifier><language>eng</language><publisher>India: Wolters Kluwer - Medknow</publisher><subject>Review</subject><ispartof>Journal of family medicine and primary care, 2021-03, Vol.10 (3), p.1095-1101</ispartof><rights>Copyright: © 2021 Journal of Family Medicine and Primary Care.</rights><rights>Copyright: © 2021 Journal of Family Medicine and Primary Care 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c290t-68a6cd4776edfe77417104aaa80fcea5190b99a063f3da1517b8d7872c0d03cb3</citedby><cites>FETCH-LOGICAL-c290t-68a6cd4776edfe77417104aaa80fcea5190b99a063f3da1517b8d7872c0d03cb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140278/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140278/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,733,786,790,891,27957,27958,53827,53829</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34041136$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yadav, Ramakant</creatorcontrib><creatorcontrib>Bajpai, Prashant K</creatorcontrib><creatorcontrib>Srivastava, Dhiraj K</creatorcontrib><creatorcontrib>Kumar, Raj</creatorcontrib><title>Epidemiological characteristics, reinfection possibilities and vaccine development of SARS CoV2: A global review</title><title>Journal of family medicine and primary care</title><addtitle>J Family Med Prim Care</addtitle><description>According to the World Health Organization (WHO), there are 37,704,153 cases and 10,79,029 deaths due to COVID-19 till the 13th October 2020 in the world. Day by day, rise in the number of COVID-19 deaths has created great pressure on health facilities, governmental bodies, and health workers. There is a need for knowledge regarding lifecycle, transmission, and different strains of SARSCoV2, so that countries can stop the disease as early as possible. The present study was conducted to review various epidemiological aspects along with measures used in the containment and prevention of this new pandemic. The scientific literature database was searched using the terms: coronavirus, 2019-nCoV, SARSCoV2, and COVID-19. Articles with appropriate topics fulfilling the objective of the present work were included. The epidemiological characteristics regarding life-cycle, intermediate hosts, viability on various surfaces, strains, case fatality rate, and their implication to reduce the transmission of SARSCoV2 have been identified. According to Centers for Disease Control and Prevention, Atlanta (updated till October 05, 2020) people with recurrent or persistent positive COVID-19 tests in South Korea and USA did not show to have live virus in their bodies. As per WHO web-page information till 15 October 2020, there were 42 candidate vaccines in clinical evaluation and 156 vaccines are in preclinical evaluation phase. As the virus can easily be transmitted to the people either via droplets, fomites, and may be via the fecal-oral route, knowledge regarding the above-mentioned areas is needed for time to be prepared for the next waves of the COVID-19 pandemic.</description><subject>Review</subject><issn>2249-4863</issn><issn>2278-7135</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNpVUU1v1DAQtRCIVqW_AAn5yIEUO3bihAPSalU-pEpIFLhaE3uyncqJg51dxL_HZUtF5zAzmo83o_cYeynFhZZCvb0dp8Vd_PW2lo20tXjCTuvadJWRqnl6l-u-0l2rTth5zreiWC9LrXvOTpQWWkrVnrLlciGPE8UQd-QgcHcDCdyKifJKLr_hCWke0a0UZ77EnGmgQCth5jB7fgDnaEbu8YAhLhPOK48jv958vebb-KN-xzd8F-JQkBMeCH-9YM9GCBnP7-MZ-_7h8tv2U3X15ePn7eaqcnUv1qrtoHVeG9OiH9EYLY0UGgA6MTqERvZi6HsQrRqVh0KAGTpvOlM74YVygzpj74-4y36Y0LvyWIJgl0QTpN82AtnHnZlu7C4ebCe1KDQWgNf3ACn-3GNe7UTZYQgwY9xnWzdKKal0I8uoOo66VAhKOD6ckcLeyWWPQj2Sq2y9-v_Dh51_4qg_qpmWtQ</recordid><startdate>202103</startdate><enddate>202103</enddate><creator>Yadav, Ramakant</creator><creator>Bajpai, Prashant K</creator><creator>Srivastava, Dhiraj K</creator><creator>Kumar, Raj</creator><general>Wolters Kluwer - Medknow</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>202103</creationdate><title>Epidemiological characteristics, reinfection possibilities and vaccine development of SARS CoV2: A global review</title><author>Yadav, Ramakant ; Bajpai, Prashant K ; Srivastava, Dhiraj K ; Kumar, Raj</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c290t-68a6cd4776edfe77417104aaa80fcea5190b99a063f3da1517b8d7872c0d03cb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yadav, Ramakant</creatorcontrib><creatorcontrib>Bajpai, Prashant K</creatorcontrib><creatorcontrib>Srivastava, Dhiraj K</creatorcontrib><creatorcontrib>Kumar, Raj</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of family medicine and primary care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yadav, Ramakant</au><au>Bajpai, Prashant K</au><au>Srivastava, Dhiraj K</au><au>Kumar, Raj</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epidemiological characteristics, reinfection possibilities and vaccine development of SARS CoV2: A global review</atitle><jtitle>Journal of family medicine and primary care</jtitle><addtitle>J Family Med Prim Care</addtitle><date>2021-03</date><risdate>2021</risdate><volume>10</volume><issue>3</issue><spage>1095</spage><epage>1101</epage><pages>1095-1101</pages><issn>2249-4863</issn><eissn>2278-7135</eissn><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>ObjectType-Review-3</notes><notes>content type line 23</notes><abstract>According to the World Health Organization (WHO), there are 37,704,153 cases and 10,79,029 deaths due to COVID-19 till the 13th October 2020 in the world. Day by day, rise in the number of COVID-19 deaths has created great pressure on health facilities, governmental bodies, and health workers. There is a need for knowledge regarding lifecycle, transmission, and different strains of SARSCoV2, so that countries can stop the disease as early as possible. The present study was conducted to review various epidemiological aspects along with measures used in the containment and prevention of this new pandemic. The scientific literature database was searched using the terms: coronavirus, 2019-nCoV, SARSCoV2, and COVID-19. Articles with appropriate topics fulfilling the objective of the present work were included. The epidemiological characteristics regarding life-cycle, intermediate hosts, viability on various surfaces, strains, case fatality rate, and their implication to reduce the transmission of SARSCoV2 have been identified. According to Centers for Disease Control and Prevention, Atlanta (updated till October 05, 2020) people with recurrent or persistent positive COVID-19 tests in South Korea and USA did not show to have live virus in their bodies. As per WHO web-page information till 15 October 2020, there were 42 candidate vaccines in clinical evaluation and 156 vaccines are in preclinical evaluation phase. As the virus can easily be transmitted to the people either via droplets, fomites, and may be via the fecal-oral route, knowledge regarding the above-mentioned areas is needed for time to be prepared for the next waves of the COVID-19 pandemic.</abstract><cop>India</cop><pub>Wolters Kluwer - Medknow</pub><pmid>34041136</pmid><doi>10.4103/jfmpc.jfmpc_2151_20</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2249-4863
ispartof Journal of family medicine and primary care, 2021-03, Vol.10 (3), p.1095-1101
issn 2249-4863
2278-7135
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8140278
source PubMed Central
subjects Review
title Epidemiological characteristics, reinfection possibilities and vaccine development of SARS CoV2: A global review
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-22T18%3A36%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epidemiological%20characteristics,%20reinfection%20possibilities%20and%20vaccine%20development%20of%20SARS%20CoV2:%20A%20global%20review&rft.jtitle=Journal%20of%20family%20medicine%20and%20primary%20care&rft.au=Yadav,%20Ramakant&rft.date=2021-03&rft.volume=10&rft.issue=3&rft.spage=1095&rft.epage=1101&rft.pages=1095-1101&rft.issn=2249-4863&rft.eissn=2278-7135&rft_id=info:doi/10.4103/jfmpc.jfmpc_2151_20&rft_dat=%3Cproquest_pubme%3E2533313451%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c290t-68a6cd4776edfe77417104aaa80fcea5190b99a063f3da1517b8d7872c0d03cb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2533313451&rft_id=info:pmid/34041136&rfr_iscdi=true